Development and validation of prediction scores for nosocomial infections, reoperations, and adverse events in the daily clinical setting of neurosurgical patients with cerebral and spinal tumors

Lohmann, Sebastian; Brix, Tobias; Varghese, Julian; Warneke, Nils; Schwake, Michael; Molina, Eric Suero; Holling, Markus; Stummer, Walter; Schipmann, Stephanie

Research article (journal) | Peer reviewed

Abstract

OBJECTIVE Various quality indicators are currently under investigation, aiming at measuring the quality of care in neurosurgery; however, the discipline currently lacks practical scoring systems for accurately assessing risk. The aim of this study was to develop three accurate, easy-to-use risk scoring systems for nosocomial infections, reoperations, and adverse events for patients with cerebral and spinal tumors. METHODS The authors developed a semiautomatic registry with administrative and clinical data and included all patients with spinal or cerebral tumors treated between September 2017 and May 2019. Patients were further divided into development and validation cohorts. Multivariable logistic regression models were used to develop risk scores by assigning points based on beta coefficients, and internal validation of the scores was performed. RESULTS In total, 1000 patients were included. An unplanned 30-day reoperation was observed in 6.8% of patients. Nosocomial infections were documented in 7.4% of cases and any adverse event in 14.5%. The risk scores comprise variables such as emergency admission, nursing care level, ECOG performance status, and inflammatory markers on admission. Three scoring systems, NoInfECT for predicting the incidence of nosocomial infections (low risk, 1.8%; intermediate risk, 8.1%; and high risk, 26.0% [p < 0.001]), LEUCut for 30-day unplanned reoperations (low risk, 2.2%; intermediate risk, 6.8%; and high risk, 13.5% [p < 0.001]), and LINC for any adverse events (low risk, 7.6%; intermediate risk, 15.7%; and high risk, 49.5% [p < 0.001]), showed satisfactory discrimination between the different outcome groups in receiver operating characteristic curve analysis (AUC >= 0.7). CONCLUSIONS The proposed risk scores allow efficient prediction of the likelihood of adverse events, to compare quality of care between different providers, and further provide guidance to surgeons on how to allocate preoperative care.

Details about the publication

JournalJournal of Neurosurgery (J Neurosurg)
Volume134
Issue4
StatusPublished
Release year2020
DOI10.3171/2020.1.JNS193186
Link to the full texthttps://pubmed.ncbi.nlm.nih.gov/32197255/
Keywordsquality indicators; brain tumor; risk assessment; risk score; infection

Authors from the University of Münster

Brix, Tobias
Institute of Medical Informatics
Holling, Markus
Clinic for Neurosurgery
Schipmann, Stephanie
Clinic for Neurosurgery
Schwake, Michael
Clinic for Neurosurgery
Stummer, Walter
Clinic for Neurosurgery
Suero Molina, Eric Jose
Clinic for Neurosurgery
Varghese, Julian
Institute of Medical Informatics
Warneke, Nils
Clinic for Neurosurgery